The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

By M. Bartnik, L. Rydén, R. Ferrari, K. Malmberg, K. Pyörälä, M. Simoons, Eberhard Standl, J. Soler‐Soler, J. Ohrvik. European Heart Journal, 2004

679 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. (2013, methodology): “These results were confirmed in the much larger Euro Heart Survey performed in 110 medical centres in 25 nations.(25) In Euro Heart, 4961 subjects with coronary artery disease but no known diabetes were enrolled, and a majority of these patients were subsequently found to have diabetes, impaired glu”
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2012, neutral): “a sign of disturbed long-term glucose metabolism, because of undiagnosed diabetes or impaired glucose tolerance.(200) It was recent-”
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries (2016, background): “The Euro Heart Survey of Diabetes and the Heart, a multicentre prospective observational study in 4961 coronary patients from 25 countries conducted in 2003–2004, demonstrated that abnormal glucose regulation affected a majority of patients with coronary artery disease and routine use of an oral glu”